MetroWest

Natick-based Aleta Biotherapeutics, a cancer treatment development company, has received clearance from the U.K. Medicines and Healthcare products Regulatory Agency to investigate a new therapeutic for lymphoma in a clinical trial.

Boston utility company Eversource has begun drilling 90 bore holes, each 600-700 feet deep, as part of its effort to connect 140 customers in Framingham with geothermal energy.

Framingham clean energy firm Ameresco completed an acquisition of a Los Alamitos, California microgrid. The system, located at a joint military forces training base, has a microgrid, solar panels, and battery energy storage. 

Boston-based streaming technology company SeaChange International, which was formerly based in Acton, will voluntarily delist its stock from The NASDAQ Stock market.

Marlborough-based biotechnology and manufacturing firm Boston Scientific has received U.S. Food and Drug Administration approval for a new catheter system for patients with atrial fibrillation, which is a type of abnormal heartbeat.

Marlborough medical device firm ReWalk Robotics in Marlborough has agreed to acquire AlterG, a California company specializing in technology for use in physical and neurological rehabilitation.

Methods Machine Tools named Richard Alton, formerly of Wisconsin-based Manitou Americas, as its new CEO.

Heartland Water Technology in Hudson named board member Christopher Beaufait as its new president and CEO, taking over for Earl Jones, who had been CEO since 2016, as part of a planned transition.

Maryland-based Thomas Park Investments purchased a Reliant Medical Group-anchored medical building in Southborough.

Definitive Healthcare completed layoffs Monday of approximately 4% of its workforce, impacting more than 40 employees. This is its second round of layoffs d in 2023.